Everyone is worried about Chinese models, but the frontier labs will be fine; we need to enable open U.S. alternatives.
An immune system has one design flaw that no amount of engineering ever fully solves: the same mechanisms that let it ...
"Q1 consolidated revenue was $24.3 million" and "Q1 operating profit was $3.4 million or 14% of revenue" (Controller Jeff Hoffman). Management tied near-term profit optics to accelerated member ...
“The appointment of Sameer Deen as COO, the enhanced open market repurchase program and reaffirming of our '26 full year financial outlook. This reflects the great confidence we have in our business ...